# Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes

> **NCT00191178** · PHASE4 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 60 (—)

## Conditions studied

- Type 2 Diabetes

## Interventions

- **DRUG:** insulin lispro protamine suspension:insulin lispro rDNA origin low mix
- **DRUG:** insulin glargine

## Key facts

- **NCT ID:** NCT00191178
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-08
- **Primary completion:** —
- **Final completion:** 2005-07
- **Target enrollment:** 60 (—)
- **Last updated:** 2010-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00191178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00191178, "Effects of Insulin in Perceived Mood Symptoms in Patients With Type 2 Diabetes". Retrieved via AI Analytics 2026-09-09 from https://api.ai-analytics.org/clinical/NCT00191178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*